Navigation Links
Treatment in Medical Technology

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... compared with FOLFOX alone in the first-line treatment of patients with KRAS wild-type metastatic ... Originally designed to compare the treatment effect in the overall population, the study was ... U.S. Food and Drug Administration (FDA) for the treatment of mCRC. Vectibix was approved in the United ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... with a 25% reduction in LDL-C after 26 weeks of treatment with mipomersen versus 3% for placebo and all of ... levels with current therapies and who need new treatment options. Isis and Genzyme reported ... Phase 1 clinical study of EXC 001( )for the local treatment of fibrosis. Isis' ...

Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors

... Oncology, Inc. , continues to offer cutting-edge treatment options to its patients through the addition of ... allows physicians to deliver precise radiation treatment to a patient's cancerous tumor and is rapidly becoming the treatment of choice for certain types of cancer. ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

... by the U.S. Food and Drug Administration for the treatment of osteoporosis in women and men at high risk of ... femoral neck BMD was 1.1 percent. In the 12-month treatment period, patients receiving the highest dose of ... support its promise as a next-generation anabolic treatment for osteoporosis," said C. Richard Lyttle, PhD, ...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... the efficacy of Labopharm's formulation as a treatment for depression, as well as its positive effect on ... group, four percent of patients discontinued treatment due to somnolence or sedation. The drop out rate ... product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory ...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

... colorectal cancer trials have not shown a treatment benefit for Erbitux/Vectibix in patients whose ... the use of the drugs is not recommended for the treatment of colorectal cancer patients with these ... can potentially eliminate ineffective patient treatment and decrease health care expenses. ARUP's ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... as an intravenous (IV) infusion in the treatment of bone metastases in 1,776 advanced cancer ... the time to first SRE associated with denosumab treatment was not statistically superior compared to Zometa ... jaw (ONJ) were balanced and infrequent in both treatment groups (10 patients receiving denosumab as ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... suspension for the acute and maintenance treatment of schizophrenia in adults on Friday, July 31, ... can be managed in most patients with appropriate treatment that includes continuous, long-term therapy with ... to ensure that patients are following their treatment plans in order to help reduce the risk of ...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

... and Drug Administration (FDA) has accepted its treatment protocol for velaglucerase alfa and that Shire ... Patients aged two years and older who were treatment naive were eligible to participate in the study ... Gaucher patients. The prospect of having another treatment option available to help patients achieve ...

Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C

... its phase I clinical trial of PSI-7851 for the treatment of hepatitis C (HCV). PSI-7851 is a second ... become a key component of any future combination treatment regimen for HCV." Conference Call and ... analog currently in development for the treatment of chronic HCV infection. PSI-7851 has ...

British Woman Celebrates a Year of Living Cancer-Free

... designer Joanne Scott went through a cancer treatment that changed her life -- and made history to ... tumor-activated natural killer (TaNK) cells as a treatment for leukemia. Her doctors at the Royal ... she said, "like I had before." But the new treatment succeeded where the others had failed, sparking ...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

... May Potentially Lead to New Approach to Stroke treatment BOCA RATON, Fla., July 30 ... in Boca Raton, FL, the data suggests that this treatment is safe and potentially leads to improved ... in-depth in order to bring more clarity to the treatment of late-presenting stroke patients. The ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... tablets as effective and safe for the acute treatment of manic or mixed episodes associated with ... I disorder in adults and in favor of use in acute treatment of schizophrenia in adults. If approved by FDA, ... bipolar I disorder, including patients starting treatment and those who need ...

New Powder Speeds Healing of Difficult Foot Wounds

... to rapidly heal foot wounds and advance the treatment patients currently receive. (Logo: ... that would not heal. This powder's successful treatment of difficult foot wounds could potentially lead ... provided a painless, efficient, and protective treatment that assisted in closing the wound. The powder ...

Is Your Hair Taking a Break?

... of hair loss women experience and the current treatment options. "Hair loss is a very ... length or diameter. Fortunately, several treatment options are effective for women with hair loss. ... patients will experience hair regrowth even with treatment -- which could have a significant negative impact ...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

... onset of menopause -- and did not wait to start treatment like the other group -- did experience noticeable ... patients with up-to-date information on the treatment and management of disorders of the skin, hair and ... the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... superior to traditional surgical clipping in the treatment of brain aneurysms - many studies have continued ... to the neurosciences including: advancing stroke treatment through catheter based therapy; innovating ... registry to track procedural success in the treatment of acute stroke. More information on SNIS and our ...

Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest

... after instituting new therapeutic hypothermia treatment for heart attack patients, Providence Tarzana Medical Center has applied the body-cooling treatment in three cases - and each patient showed ... working with paramedics to apply hypothermia treatment en route to hospitals, Dr. Brewster said. ...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

... bone density score, being vigilant about their treatment and talking to their doctor, nurse or other ... due to the frailty of her jaw. She quickly sought treatment from area doctor, Chad Deal, M.D. and, thanks to ... and men that affect the prevention, diagnosis and treatment of disease. More information is available at ...

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

... INTUNIV INTUNIV is being studied for the treatment of ADHD in children and adolescents aged 6 to 17 ... the mechanism of action of guanfacine in the treatment of ADHD is not fully understood, preclinical ... research supports the use of guanfacine for the treatment of ADHD.(6) Safety was also evaluated ...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... trial designed to evaluate dirucotide for the treatment of SPMS that completed enrollment in August 2008. ... with or without relapses(vii). There are few treatment options available for these patients(viii). ... Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis. In December 2007, BioMS ...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

... is being studied by Wyeth Pharmaceuticals for the treatment of moderate-to-severe menopausal vasomotor ... to adverse events were similar among the active treatment groups and placebo. About SMART-1 ... months had elapsed since their last assessment. treatment with BZA/CE doses being considered for ...

Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression

... technology to identify novel pathways for the treatment of central nervous system (CNS) diseases, ... of low dose buspirone and melatonin, for the treatment of major depressive disorder (MDD). The data were ... validation of neurogenesis as a target for the treatment of mood disorders like depression, in contrast to ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... Rate (ESR) Efficacy Results treatment N of Pts ACR 20 ACR 50 ACR 70 ... --- --- --- --- TASKi3 treatment Emergent Adverse Events ... had failed to respond to at least one biologic treatment (such as TNF inhibitors). The patients were ...

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

... the world to treat patients with a breakthrough treatment of skin cancer. Located within Riverview ... to introduce electronic brachytherapy as a treatment for non-melanoma skin cancer," said Dr. Welsh. ... available in June, we shorten the course of treatment and precisely conform the radiation dose to the ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... and are now in human clinical trials for the treatment of HIV/AIDS. This is the first example of ... and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development ... in advancing the prevention, diagnosis and treatment of disease and injury through education, ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

... fumarate combination for the maintenance treatment of asthma in patients 12 years of age and older. ... would represent an important additional treatment option for physicians and their patients and ... furoate and formoterol fumarate for the treatment of asthma in patients younger than 12 years of ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... as we move closer to providing an alternative treatment for this controversial disorder. It's a small market, but we feel that it's our duty to make this treatment available to the medical profession." ... been made. About Moapar(R) In the treatment of sexual deviations in men, ...

Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations

... as we move closer to providing an alternative treatment for this controversial disorder. It's a small market, but we feel that it's our duty to make this treatment available to the medical profession." ... been made. About Moapar(R) In the treatment of sexual deviations in men, ...

FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent

... more than 2,700 patients, which showed that treatment with the combination of Tekturna and HCTZ offered ... their blood pressure goals. Current US treatment guidelines support the first-line use of ... on Prevention, Detection, Evaluation, and treatment of High Blood Pressure (JNC7) recommends that ...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... cancer, ovarian, or colorectal cancer following treatment with platinum containing regimens where high ... by the European Organization for Research and treatment of Cancer (EORTC). About Systems ... results to predict the safe and effective treatment of cancer (including the potential for liver ...

UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPar's Investigational Cancer Drug BSI-201

... trial of BSI-201 which is a very promising new treatment for metastatic triple negative breast cancer," ... is a potential game changing therapy in the treatment of triple-negative breast cancer. US Oncology ... supports one of the nation's foremost cancer treatment and research networks, accelerating the ...

Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)

... in the discovery and development of drugs for the treatment of human viral diseases, today announced that it ... of 2'-methyl guanosine nucleotide, for the treatment of HCV. This double-blind, ... End of treatment Mean Patients with 1 log10 or ...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

... A1C of 7.0 percent in those treated with Lantus. treatment with exenatide once weekly also produced a ... and development, Amylin Pharmaceuticals. "Both treatment arms started with a baseline A1C of 8.3 percent ... patients completed the study. During the 26-week treatment period, the most frequently reported adverse ...

New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed

... to or at week 48.(1) In patients who began study treatment with viral loads above 100,000 copies/mL, 60 ... of <50 copies/mL. In patients who began study treatment with viral loads below 100,000 copies/mL, 77 ... with other antiretroviral agents for the treatment of HIV infection. VIRAMUNE does not ...

First Potential Lupus-Specific Treatment in Sight

... at their disposal to provide the individualized treatment that lupus requires. "We are grateful ... to develop a new, safe, effective and tolerable treatment for lupus, to the physicians who have ... and potentially fatal, yet no satisfactory treatment or cure exists. About the LFA The ...

Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

... rates comparable between belimumab and placebo treatment groups. (Logo: ... Chief Executive Officer, HGS. "Given the limited treatment options currently available, patients would ... BENLYSTA is an outstanding example of the type of treatment HGS is working to develop and bring to patients. ...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

... dose of peramivir (either 300 mg or 600 mg) and treatment with oral oseltamivir phosphate 75 mg ... disease requiring pharmacotherapy, or current treatment with any immunosuppressive drug. Peramivir was ... as they indicate the promise of peramivir as a treatment for influenza," commented Dr. William P. ...

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

... ZURICH, July 16 /PRNewswire/ -- An innovative treatment for infections of the respiratory tract in cystic ... formulation of tobramycin and an innovative treatment for infections of the respiratory tract in ... of patients with B. cepacia infection, makes the treatment of these patients exceedingly complex. Tobramycin ...

Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease

... enzyme replacement therapy in development for the treatment of Type I Gaucher disease. Shire is working with ... On July 6th, Shire announced that it filed a treatment protocol for velaglucerase alfa at the request of ... in the US. Under the conditions of the treatment protocol, Shire would provide velaglucerase ...
Other Contents
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure plays ... a while. Hypertension – the medical term for high blood ... early 1800s, and the inflatable cuff that,s used in measuring ... however, mean there,s nothing new about hypertension, its triggers and ...
(Date:12/10/2014)... 2014 You,ve been here before: you desperately need to sign ... key or the answer to your secret question. What,s your dog,s ... Hoyos Labs , a digital infrastructure security company, launches ... frustration that comes with usernames, passwords and PINs – 1U ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a new ... this $50 million capital project is part of a larger ... The medical education building will be located in ... to 525@vine in Wake Forest Innovation Quarter. Construction will begin ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... January 22, 2015 Juvent Sports ( ... the 2015 PGA Merchandise Show to bestow a Juvent ... female amateur golfer, Arlene McKitrick. The award commemorated and ... golf tournament win. She won her first amateur tournament ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
Other TagsOther Tags